Homologous recombination

Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
Antonella Pietragalla, Martina Arcieri, Claudia Marchetti, Giovanni Scambia, Anna Fagotti

International Journal of Gynecologic Cancer Nov 2020, 30 (11) 1803-1810; DOI: 10.1136/ijgc-2020-001556
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers
Anca Chelariu-Raicu, Graziela Zibetti Dal Molin, Robert L Coleman

International Journal of Gynecologic Cancer Oct 2020, 30 (10) 1608-1618; DOI: 10.1136/ijgc-2020-001789
Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity
Rachel L. O’Donnell, Angelika Kaufmann, Laura Woodhouse, Aiste McCormick, Paul A. Cross, Richard J. Edmondson, Nicola J. Curtin

International Journal of Gynecologic Cancer Jul 2016, 26 (6) 1004-1011; DOI: 10.1097/IGC.0000000000000745
Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents
Aiste McCormick, Eleanor Earp, Charlotte Leeson, Michelle Dixon, Rachel O’Donnell, Angelika Kaufmann, Richard J. Edmondson

International Journal of Gynecologic Cancer May 2016, 26 (4) 632-639; DOI: 10.1097/IGC.0000000000000657

Main menu